Entering text into the input field will update the search result below

Impax Laboratories (IPXL) Presents at Morgan Stanley 15th Annual Global Healthcare Conference (Transcript)

Sep. 12, 2017 3:34 PM ETAmneal Pharmaceuticals, Inc. (AMRX)
SA Transcripts profile picture
SA Transcripts

Impax Laboratories, Inc. (IPXL) Morgan Stanley 15th Annual Global Healthcare Conference September 12, 2017 10:35 AM ET


Paul Bisaro – Chief Executive Officer

Bryan Reasons – Chief Financial Officer


David Risinger – Morgan Stanley

David Risinger

So thanks everybody for joining us for the Impax Lab session. It's very much my pleasure to welcome the CEO and CFO. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.

Many of you know Paul Bisaro, he has over 25 years of pharmaceutical industry experience.

Paul Bisaro

Number is long, big number.

David Risinger

And we're pleased to have him join us today. And Bryan Reasons is the CFO. He served as CFO since December of 2012 prior to joining Impax, he served as Vice President of Finance at Cephalon. So he has several years of experience in the pharmaceutical industry as well.

I thought it would make sense to start with a high-level question, Paul. You're keeping everybody on their toes. I don’t think it's been too long since you joined as CEO and there have been a number of developments at Impax and for the industry as well. So it would be great for you to frame your vision for Impax. Well, update us on what's happened briefly and then frame your vision for Impax going forward.

Paul Bisaro

Sure. First of all, David thanks for having us, we really appreciate you taking the time with us and we’re looking forward to meeting many of you in the breakout sessions as well.

I think I've been in Impax now about six or seven months. It seems like a long time but time has been going very quickly. I think, the first thing we try to do is assess the situation, understand what we could do in the short-term. What the medium-term situation look

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.